Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
83 participants
OBSERVATIONAL
2020-05-03
2024-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VIA Disc NP Registry 3.0
NCT06345690
VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs
NCT05201287
VIA Disc Nucleus Pulposus Older Patients Pilot
NCT05412277
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
NCT06778447
Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain
NCT03709901
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VIA Disc NP
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment
VIA Disc NP (HCT/P)
VIA Disc NP - Allograft tissue injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIA Disc NP (HCT/P)
VIA Disc NP - Allograft tissue injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand and sign the informed consent form (as applicable)
* VIA Disc NP injection is scheduled for 1 or more levels
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VIVEX Biologics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Finstein, MHA
Role: STUDY_DIRECTOR
Vivex Biologics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gateway Pain Solutions
Mesa, Arizona, United States
Source Healthcare
Santa Monica, California, United States
Interventional Pain Management
Walnut Creek, California, United States
MD Pain
Englewood, Colorado, United States
Western Rockies Interventional Pain Specialists
Grand Junction, Colorado, United States
The Denver Spine & Pain Institute
Greenwood Village, Colorado, United States
International Spine, Pain & Performance Center
Washington D.C., District of Columbia, United States
The Orthopedic Institute
Gainesville, Florida, United States
Southwest Florida Pain Center
Port Charlotte, Florida, United States
FAST MD
Tampa, Florida, United States
Florida Spine & Pain Specialists
Tampa, Florida, United States
Florida Pain Medicine
Wesley Chapel, Florida, United States
Orthopaedic Research Foundation
Indianapolis, Indiana, United States
Anesthesiology & Pain Consultants
Lafayette, Louisiana, United States
Interventional Pain Specialists
Opelousas, Louisiana, United States
Michigan Interventional Pain Center
Brownstown, Michigan, United States
Forest Health
Ypsilanti, Michigan, United States
Nevada Advanced Pain Specialists
Reno, Nevada, United States
Ainsworth Institute of Pain Management
New York, New York, United States
Premier Pain Solutions
Asheville, North Carolina, United States
Crystal Coast Pain Management
New Bern, North Carolina, United States
Premier Pain
Loveland, Ohio, United States
Invictus Healthcare System
Tulsa, Oklahoma, United States
Center for Interventional Pain Spine
Chadds Ford, Pennsylvania, United States
Atlantic Coast Pain Management
Conway, South Carolina, United States
Southeastern Spine Institute
Mt. Pleasant, South Carolina, United States
Specialist in Pain Management
Chattanooga, Tennessee, United States
Vertex Spine
Franklin, Tennessee, United States
Ortho Spine Surgery Institute
North Richland Hills, Texas, United States
MD SpineCare and DC Medical Solutions
San Antonio, Texas, United States
Advanced Spine and Pain Center
San Antonio, Texas, United States
The Sprintz Center for Pain
Shenandoah, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VIV-001-020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.